Healthcare provider profile · identity verified

Ryan James Becker, M.D.

Family Practice · SHELDON, IA · NPI 1336431055

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	699	166
Omeprazole	Omeprazole	584	122
Levothyroxine Sodium	Levothyroxine Sodium	537	103
Losartan Potassium	Losartan Potassium	517	103
Furosemide	Furosemide	489	86
Metoprolol Succinate	Metoprolol Succinate	408	74
Amlodipine Besylate	Amlodipine Besylate	358	78
Tamsulosin Hcl	Tamsulosin Hcl	314	73
Gabapentin	Gabapentin	311	64
Lisinopril	Lisinopril	280	66
Rosuvastatin Calcium	Rosuvastatin Calcium	227	60
Sertraline Hcl	Sertraline Hcl	213	44
Hydrochlorothiazide	Hydrochlorothiazide	210	41
Eliquis	Apixaban	195	30
Potassium Chloride	Potassium Chloride	191	47
Famotidine	Famotidine	188	33
Glipizide	Glipizide	184	35
Metformin Hcl Er	Metformin Hcl	175	34
Metformin Hcl	Metformin Hcl	172	33
Glimepiride	Glimepiride	170	27
Duloxetine Hcl	Duloxetine Hcl	168	36
Allopurinol	Allopurinol	157	35
Pantoprazole Sodium	Pantoprazole Sodium	152	29
Spironolactone	Spironolactone	147	30
Simvastatin	Simvastatin	146	37
Metoprolol Tartrate	Metoprolol Tartrate	142	26
Buspirone Hcl	Buspirone Hcl	135	21
Meloxicam	Meloxicam	119	35
Montelukast Sodium	Montelukast Sodium	119	20
Fluticasone Propionate	Fluticasone Propionate	111	29
Cephalexin	Cephalexin	108	56
Jantoven	Warfarin Sodium	107	24
Trazodone Hcl	Trazodone Hcl	96	22
Clopidogrel	Clopidogrel Bisulfate	95	18
Donepezil Hcl	Donepezil Hcl	95	13
Albuterol Sulfate Hfa	Albuterol Sulfate	91	27
Tramadol Hcl	Tramadol Hcl	91	36
Mirtazapine	Mirtazapine	90	15
Finasteride	Finasteride	81	19
Atenolol	Atenolol	78	15
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	73	16
Escitalopram Oxalate	Escitalopram Oxalate	72	14
Jardiance	Empagliflozin	72	suppressed
Xarelto	Rivaroxaban	72	14
Zolpidem Tartrate	Zolpidem Tartrate	71	13
Ozempic	Semaglutide	70	17
Warfarin Sodium	Warfarin Sodium	69	19
Prednisone	Prednisone	68	50
Clonazepam	Clonazepam	66	13
Ezetimibe	Ezetimibe	64	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	63	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	60	20
Januvia	Sitagliptin Phosphate	59	12
Alendronate Sodium	Alendronate Sodium	58	13
Lorazepam	Lorazepam	57	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	55	16
Amitriptyline Hcl	Amitriptyline Hcl	51	11
Fluoxetine Hcl	Fluoxetine Hcl	51	16
Pregabalin	Pregabalin	51	suppressed
Myrbetriq	Mirabegron	50	suppressed
Digoxin	Digoxin	49	11
Azithromycin	Azithromycin	47	42
Oxybutynin Chloride	Oxybutynin Chloride	47	12
Citalopram Hbr	Citalopram Hydrobromide	46	12
Memantine Hcl	Memantine Hcl	46	suppressed
Farxiga	Dapagliflozin Propanediol	44	suppressed
Raloxifene Hcl	Raloxifene Hcl	42	suppressed
Ropinirole Hcl	Ropinirole Hcl	42	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	41	suppressed
Baclofen	Baclofen	40	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	40	suppressed
Tizanidine Hcl	Tizanidine Hcl	39	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	38	11
Amoxicillin	Amoxicillin	36	19
Bupropion Xl	Bupropion Hcl	36	13
Pravastatin Sodium	Pravastatin Sodium	34	suppressed
Carvedilol	Carvedilol	33	suppressed
Benazepril Hcl	Benazepril Hcl	32	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	32	20
Ipratropium Bromide	Ipratropium Bromide	31	suppressed
Oxycodone Hcl	Oxycodone Hcl	29	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	28	14
Lovastatin	Lovastatin	28	suppressed
Midodrine Hcl	Midodrine Hcl	28	suppressed
Paroxetine Hcl	Paroxetine Hcl	28	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	26	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	25	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	25	20
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	25	suppressed
Celecoxib	Celecoxib	24	suppressed
Fenofibrate	Fenofibrate	24	suppressed
Gemfibrozil	Gemfibrozil	24	suppressed
Propranolol Hcl	Propranolol Hcl	24	suppressed
Klor-Con M20	Potassium Chloride	22	suppressed
Solifenacin Succinate	Solifenacin Succinate	22	suppressed
Tresiba Flextouch U-200	Insulin Degludec	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	21	suppressed
Cefuroxime	Cefuroxime Axetil	20	17
Memantine Hcl Er	Memantine Hcl	20	suppressed
Metolazone	Metolazone	20	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	20	suppressed
Brilinta	Ticagrelor	19	suppressed
Fentanyl	Fentanyl	19	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	19	suppressed
Symbicort	Budesonide/Formoterol Fumarate	19	suppressed
Chlordiazepoxide Hcl	Chlordiazepoxide Hcl	18	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Ondansetron Odt	Ondansetron	18	16
Phenytoin Sodium Extended	Phenytoin Sodium Extended	18	suppressed
Primidone	Primidone	18	suppressed
Breo Ellipta	Fluticasone/Vilanterol	17	suppressed
Synthroid	Levothyroxine Sodium	17	suppressed
Aripiprazole	Aripiprazole	16	suppressed
Enalapril Maleate	Enalapril Maleate	16	suppressed
Fluconazole	Fluconazole	16	11
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	16	suppressed
Latanoprost	Latanoprost	16	suppressed
Sucralfate	Sucralfate	16	suppressed
Topiramate	Topiramate	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	13
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Divalproex Sodium Er	Divalproex Sodium	14	suppressed
Erythromycin	Erythromycin Base	14	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Rivastigmine	Rivastigmine Tartrate	14	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	13	suppressed
Armour Thyroid	Thyroid,pork	13	suppressed
Carbamazepine Er	Carbamazepine	13	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	13	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	13	suppressed
Nitroglycerin	Nitroglycerin	13	12
Risperidone	Risperidone	13	suppressed
Tegretol	Carbamazepine	13	suppressed
Cholestyramine	Cholestyramine (With Sugar)	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Flecainide Acetate	Flecainide Acetate	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Levemir Flexpen	Insulin Detemir	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Varenicline Tartrate	Varenicline Tartrate	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Cefdinir	Cefdinir	11	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	11	suppressed
Methylprednisolone	Methylprednisolone	11	11
Mupirocin	Mupirocin	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error